(Q38996793)
Statements
Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition (English)
Stefania Napolitano
Donata Vitagliano
Anna Nappi
Davide Ciardiello
Erika Martinelli
Fortunato Ciardiello